Latest schizophrenia Stories
Pharmaceutical manufacturer, Johnson & Johnson, loses $2.5 million verdict for marketing of Risperdal, a potent antipsychotic that caused female breast growth in a young boy the case revealed.
The Firm is representing numerous plaintiffs who have also filed Risperdal lawsuits alleging the atypical antipsychotic medication caused male breast growth. New
A former U.S.
Defense motion granted in a case that is part of a mass tort litigation brought over Janssen Pharmaceutical’s antipsychotic medication, Risperdal. Port Washington,
DALLAS, January 22, 2015 /PRNewswire/ -- The Global Anxiety Disorders Market 2015-2019 research report, now available with ReportsnReports.com, says that in addition to
BUDAPEST, Hungary and DUBLIN, Jan. 20, 2015 /PRNewswire/ -- Gedeon Richter Plc.
TITUSVILLE, N.J., Jan. 19, 2015 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that the U.S.
The Firm is representing numerous individuals in Risperdal lawsuits that are currently pending in the Pennsylvania proceeding, all of which allege the antipsychotic drug may cause men and boys
SOUTH SAN FRANCISCO, Calif., Jan.
The Firm is currently representing numerous U.S.